de la fuente revenga - Search Results

Year	Number of Results
2010	2
2013	1
2015	4
2016	4
2017	5
2018	6
2019	3
2020	2
2021	4
2022	6
2024	2
2025	1
2026	3

1

Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice.

de la Fuente Revenga M, Zhu B, Guevara CA, Naler LB, Saunders JM, Zhou Z, Toneatti R, Sierra S, Wolstenholme JT, Beardsley PM, Huntley GW, Lu C, González-Maeso J. de la Fuente Revenga M, et al. Cell Rep. 2021 Oct 19;37(3):109836. doi: 10.1016/j.celrep.2021.109836. Cell Rep. 2021. PMID: 34686347 Free PMC article.

2

Molecular targets of psychedelic-induced plasticity.

Jaster AM, de la Fuente Revenga M, González-Maeso J. Jaster AM, et al. Among authors: de la fuente revenga m. J Neurochem. 2022 Jul;162(1):80-88. doi: 10.1111/jnc.15536. Epub 2021 Nov 15. J Neurochem. 2022. PMID: 34741320 Free PMC article. Review.

3

Ayahuasca: Pharmacology, neuroscience and therapeutic potential.

Domínguez-Clavé E, Soler J, Elices M, Pascual JC, Álvarez E, de la Fuente Revenga M, Friedlander P, Feilding A, Riba J. Domínguez-Clavé E, et al. Among authors: de la fuente revenga m. Brain Res Bull. 2016 Sep;126(Pt 1):89-101. doi: 10.1016/j.brainresbull.2016.03.002. Epub 2016 Mar 11. Brain Res Bull. 2016. PMID: 26976063 Review.

4

Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT_2A receptor.

Gaitonde SA, Avet C, de la Fuente Revenga M, Blondel-Tepaz E, Shahraki A, Pastor AM, Talagayev V, Robledo P, Kolb P, Selent J, González-Maeso J, Bouvier M. Gaitonde SA, et al. Among authors: de la fuente revenga m. Mol Psychiatry. 2024 Sep;29(9):2753-2764. doi: 10.1038/s41380-024-02531-7. Epub 2024 Apr 2. Mol Psychiatry. 2024. PMID: 38561467 Free PMC article.

5

Synaptopathies: synaptic dysfunction in neurological disorders - A review from students to students.

Lepeta K, Lourenco MV, Schweitzer BC, Martino Adami PV, Banerjee P, Catuara-Solarz S, de La Fuente Revenga M, Guillem AM, Haidar M, Ijomone OM, Nadorp B, Qi L, Perera ND, Refsgaard LK, Reid KM, Sabbar M, Sahoo A, Schaefer N, Sheean RK, Suska A, Verma R, Vicidomini C, Wright D, Zhang XD, Seidenbecher C. Lepeta K, et al. Among authors: de la fuente revenga m. J Neurochem. 2016 Sep;138(6):785-805. doi: 10.1111/jnc.13713. Epub 2016 Sep 8. J Neurochem. 2016. PMID: 27333343 Free PMC article. Review.

6

Recent Advances in Neurogenic Small Molecules as Innovative Treatments for Neurodegenerative Diseases.

Herrera-Arozamena C, Martí-Marí O, Estrada M, de la Fuente Revenga M, Rodríguez-Franco MI. Herrera-Arozamena C, et al. Among authors: de la fuente revenga m. Molecules. 2016 Sep 1;21(9):1165. doi: 10.3390/molecules21091165. Molecules. 2016. PMID: 27598108 Free PMC article. Review.

7

Cell-type-specific brain methylomes profiled via ultralow-input microfluidics.

Ma S, de la Fuente Revenga M, Sun Z, Sun C, Murphy TW, Xie H, González-Maeso J, Lu C. Ma S, et al. Among authors: de la fuente revenga m. Nat Biomed Eng. 2018 Mar;2(3):183-194. Epub 2018 Mar 7. Nat Biomed Eng. 2018. PMID: 29963329 Free PMC article.

8

Tolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT_2A Receptor Agonists in Mice.

de la Fuente Revenga M, Jaster AM, McGinn J, Silva G, Saha S, González-Maeso J. de la Fuente Revenga M, et al. ACS Chem Neurosci. 2022 Aug 17;13(16):2436-2448. doi: 10.1021/acschemneuro.2c00170. Epub 2022 Jul 28. ACS Chem Neurosci. 2022. PMID: 35900876 Free PMC article.

9

Psychedelic-like Properties of Quipazine and Its Structural Analogues in Mice.

de la Fuente Revenga M, Shah UH, Nassehi N, Jaster AM, Hemanth P, Sierra S, Dukat M, González-Maeso J. de la Fuente Revenga M, et al. ACS Chem Neurosci. 2021 Mar 3;12(5):831-844. doi: 10.1021/acschemneuro.0c00291. Epub 2021 Jan 5. ACS Chem Neurosci. 2021. PMID: 33400504 Free PMC article.

10

Differences across sexes on head-twitch behavior and 5-HT_2A receptor signaling in C57BL/6J mice.

Jaster AM, Younkin J, Cuddy T, de la Fuente Revenga M, Poklis JL, Dozmorov MG, González-Maeso J. Jaster AM, et al. Among authors: de la fuente revenga m. Neurosci Lett. 2022 Sep 25;788:136836. doi: 10.1016/j.neulet.2022.136836. Epub 2022 Aug 10. Neurosci Lett. 2022. PMID: 35963476 Free PMC article.

11

Sex-specific role for serotonin 5-HT_2A receptor in modulation of opioid-induced antinociception and reward in mice.

Sierra S, Muchhala KH, Jessup DK, Contreras KM, Shah UH, Stevens DL, Jimenez J, Cuno Lavilla XK, de la Fuente Revenga M, Lippold KM, Shen S, Poklis JL, Qiao LY, Dewey WL, Akbarali HI, Damaj MI, González-Maeso J. Sierra S, et al. Among authors: de la fuente revenga m. Neuropharmacology. 2022 May 15;209:108988. doi: 10.1016/j.neuropharm.2022.108988. Epub 2022 Feb 17. Neuropharmacology. 2022. PMID: 35183539 Free PMC article.

12

Sex-specific effects of psychedelics on prepulse inhibition of startle in 129S6/SvEv mice.

Vohra HZ, Saunders JM, Jaster AM, de la Fuente Revenga M, Jimenez J, Fernández-Teruel A, Wolstenholme JT, Beardsley PM, González-Maeso J. Vohra HZ, et al. Among authors: de la fuente revenga m. Psychopharmacology (Berl). 2022 Jun;239(6):1649-1664. doi: 10.1007/s00213-021-05913-9. Epub 2021 Aug 4. Psychopharmacology (Berl). 2022. PMID: 34345931 Free PMC article.

13

New coumarin-based fluorescent melatonin ligands. Design, synthesis and pharmacological characterization.

de la Fuente Revenga M, Herrera-Arozamena C, Fernández-Sáez N, Barco G, García-Orue I, Sugden D, Rivara S, Rodríguez-Franco MI. de la Fuente Revenga M, et al. Eur J Med Chem. 2015 Oct 20;103:370-3. doi: 10.1016/j.ejmech.2015.09.003. Epub 2015 Sep 8. Eur J Med Chem. 2015. PMID: 26367450

14

Snapshot of 5-HT _2A receptor activation in the mouse brain via IP ₁ detection.

de la Fuente Revenga M, González-Maeso J. de la Fuente Revenga M, et al. bioRxiv [Preprint]. 2024 Oct 12:2024.10.11.617861. doi: 10.1101/2024.10.11.617861. bioRxiv. 2024. PMID: 39416073 Free PMC article. Preprint.

15

Neurogenic Potential Assessment and Pharmacological Characterization of 6-Methoxy-1,2,3,4-tetrahydro-β-carboline (Pinoline) and Melatonin-Pinoline Hybrids.

de la Fuente Revenga M, Pérez C, Morales-García JA, Alonso-Gil S, Pérez-Castillo A, Caignard DH, Yáñez M, Gamo AM, Rodríguez-Franco MI. de la Fuente Revenga M, et al. ACS Chem Neurosci. 2015 May 20;6(5):800-10. doi: 10.1021/acschemneuro.5b00041. Epub 2015 Apr 9. ACS Chem Neurosci. 2015. PMID: 25815906

16

Fully automated head-twitch detection system for the study of 5-HT_2A receptor pharmacology in vivo.

de la Fuente Revenga M, Shin JM, Vohra HZ, Hideshima KS, Schneck M, Poklis JL, González-Maeso J. de la Fuente Revenga M, et al. Sci Rep. 2019 Oct 3;9(1):14247. doi: 10.1038/s41598-019-49913-4. Sci Rep. 2019. PMID: 31582824 Free PMC article.

17

Antipsychotic-induced Hdac2 transcription via NF-κB leads to synaptic and cognitive side effects.

Ibi D, de la Fuente Revenga M, Kezunovic N, Muguruza C, Saunders JM, Gaitonde SA, Moreno JL, Ijaz MK, Santosh V, Kozlenkov A, Holloway T, Seto J, García-Bea A, Kurita M, Mosley GE, Jiang Y, Christoffel DJ, Callado LF, Russo SJ, Dracheva S, López-Giménez JF, Ge Y, Escalante CR, Meana JJ, Akbarian S, Huntley GW, González-Maeso J. Ibi D, et al. Among authors: de la fuente revenga m. Nat Neurosci. 2017 Sep;20(9):1247-1259. doi: 10.1038/nn.4616. Epub 2017 Aug 7. Nat Neurosci. 2017. PMID: 28783139 Free PMC article.

18

HDAC2-dependent Antipsychotic-like Effects of Chronic Treatment with the HDAC Inhibitor SAHA in Mice.

de la Fuente Revenga M, Ibi D, Saunders JM, Cuddy T, Ijaz MK, Toneatti R, Kurita M, Holloway T, Shen L, Seto J, Dozmorov MG, González-Maeso J. de la Fuente Revenga M, et al. Neuroscience. 2018 Sep 15;388:102-117. doi: 10.1016/j.neuroscience.2018.07.010. Epub 2018 Jul 17. Neuroscience. 2018. PMID: 30025863 Free PMC article.

19

Effects of the 5-HT_2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents.

Jaster AM, Elder H, Marsh SA, de la Fuente Revenga M, Negus SS, González-Maeso J. Jaster AM, et al. Among authors: de la fuente revenga m. Psychopharmacology (Berl). 2022 Jun;239(6):1665-1677. doi: 10.1007/s00213-022-06092-x. Epub 2022 Mar 2. Psychopharmacology (Berl). 2022. PMID: 35233648 Free PMC article.

20

Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking.

Kuypers KP, Riba J, de la Fuente Revenga M, Barker S, Theunissen EL, Ramaekers JG. Kuypers KP, et al. Among authors: de la fuente revenga m. Psychopharmacology (Berl). 2016 Sep;233(18):3395-403. doi: 10.1007/s00213-016-4377-8. Epub 2016 Jul 19. Psychopharmacology (Berl). 2016. PMID: 27435062 Free PMC article.

21

The Melatonin Analog IQM316 May Induce Adult Hippocampal Neurogenesis and Preserve Recognition Memories in Mice.

Figueiro-Silva J, Antequera D, Pascual C, de la Fuente Revenga M, Volt H, Acuña-Castroviejo D, Rodríguez-Franco MI, Carro E. Figueiro-Silva J, et al. Among authors: de la fuente revenga m. Cell Transplant. 2018 Mar;27(3):423-437. doi: 10.1177/0963689717721217. Cell Transplant. 2018. PMID: 29873251 Free PMC article.

22

Novel N-Acetyl Bioisosteres of Melatonin: Melatonergic Receptor Pharmacology, Physicochemical Studies, and Phenotypic Assessment of Their Neurogenic Potential.

de la Fuente Revenga M, Fernández-Sáez N, Herrera-Arozamena C, Morales-García JA, Alonso-Gil S, Pérez-Castillo A, Caignard DH, Rivara S, Rodríguez-Franco MI. de la Fuente Revenga M, et al. J Med Chem. 2015 Jun 25;58(12):4998-5014. doi: 10.1021/acs.jmedchem.5b00245. Epub 2015 Jun 10. J Med Chem. 2015. PMID: 26023814

23

Automated quantification of head-twitch response in mice via ear tag reporter coupled with biphasic detection.

de la Fuente Revenga M, Vohra HZ, González-Maeso J. de la Fuente Revenga M, et al. J Neurosci Methods. 2020 Mar 15;334:108595. doi: 10.1016/j.jneumeth.2020.108595. Epub 2020 Jan 16. J Neurosci Methods. 2020. PMID: 31954738 Free PMC article.

24

Optical control of muscular nicotinic channels with azocuroniums, photoswitchable azobenzenes bearing two N-methyl-N-carbocyclic quaternary ammonium groups.

Herrera-Arozamena C, Estrada-Valencia M, Martí-Marí O, Pérez C, de la Fuente Revenga M, Villalba-Galea CA, Rodríguez-Franco MI. Herrera-Arozamena C, et al. Among authors: de la fuente revenga m. Eur J Med Chem. 2020 Aug 15;200:112403. doi: 10.1016/j.ejmech.2020.112403. Epub 2020 May 13. Eur J Med Chem. 2020. PMID: 32447198

25

Role of mGlu2 in the 5-HT_2A receptor-dependent antipsychotic activity of clozapine in mice.

Hideshima KS, Hojati A, Saunders JM, On DM, de la Fuente Revenga M, Shin JM, Sánchez-González A, Dunn CM, Pais AB, Pais AC, Miles MF, Wolstenholme JT, González-Maeso J. Hideshima KS, et al. Among authors: de la fuente revenga m. Psychopharmacology (Berl). 2018 Nov;235(11):3149-3165. doi: 10.1007/s00213-018-5015-4. Epub 2018 Sep 12. Psychopharmacology (Berl). 2018. PMID: 30209534 Free PMC article.

26

The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro.

Morales-García JA, de la Fuente Revenga M, Alonso-Gil S, Rodríguez-Franco MI, Feilding A, Perez-Castillo A, Riba J. Morales-García JA, et al. Among authors: de la fuente revenga m. Sci Rep. 2017 Jul 13;7(1):5309. doi: 10.1038/s41598-017-05407-9. Sci Rep. 2017. PMID: 28706205 Free PMC article.

27

Chronic clozapine treatment restrains via HDAC2 the performance of mGlu2 receptor agonism in a rodent model of antipsychotic activity.

de la Fuente Revenga M, Ibi D, Cuddy T, Toneatti R, Kurita M, Ijaz MK, Miles MF, Wolstenholme JT, González-Maeso J. de la Fuente Revenga M, et al. Neuropsychopharmacology. 2019 Jan;44(2):443-454. doi: 10.1038/s41386-018-0143-4. Epub 2018 Jul 7. Neuropsychopharmacology. 2019. PMID: 30038413 Free PMC article.

28

Assessing the Psychedelic "After-Glow" in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities.

Sampedro F, de la Fuente Revenga M, Valle M, Roberto N, Domínguez-Clavé E, Elices M, Luna LE, Crippa JAS, Hallak JEC, de Araujo DB, Friedlander P, Barker SA, Álvarez E, Soler J, Pascual JC, Feilding A, Riba J. Sampedro F, et al. Among authors: de la fuente revenga m. Int J Neuropsychopharmacol. 2017 Sep 1;20(9):698-711. doi: 10.1093/ijnp/pyx036. Int J Neuropsychopharmacol. 2017. PMID: 28525587 Free PMC article.

29

Correction: Chronic clozapine treatment restrains via HDAC2 the performance of mGlu2 receptor agonism in a rodent model of antipsychotic activity.

de la Fuente Revenga M, Ibi D, Cuddy T, Toneatti R, Kurita M, Ijaz MK, Miles MF, Wolstenholme JT, González-Maeso J. de la Fuente Revenga M, et al. Neuropsychopharmacology. 2019 Jan;44(2):455-456. doi: 10.1038/s41386-018-0255-x. Neuropsychopharmacology. 2019. PMID: 30401942 Free PMC article.

30

Differences in 5-HT2A and mGlu2 Receptor Expression Levels and Repressive Epigenetic Modifications at the 5-HT2A Promoter Region in the Roman Low- (RLA-I) and High- (RHA-I) Avoidance Rat Strains.

Fomsgaard L, Moreno JL, de la Fuente Revenga M, Brudek T, Adamsen D, Rio-Alamos C, Saunders J, Klein AB, Oliveras I, Cañete T, Blazquez G, Tobeña A, Fernandez-Teruel A, Gonzalez-Maeso J, Aznar S. Fomsgaard L, et al. Among authors: de la fuente revenga m. Mol Neurobiol. 2018 Mar;55(3):1998-2012. doi: 10.1007/s12035-017-0457-y. Epub 2017 Mar 6. Mol Neurobiol. 2018. PMID: 28265857 Free PMC article.

31

Validation of schizophrenia gene expression profile in a preclinical model of maternal infection during pregnancy.

Lopez-Gimenez JF, de la Fuente Revenga M, Ruso-Julve F, Saunders JM, Moreno JL, Crespo-Facorro B, González-Maeso J. Lopez-Gimenez JF, et al. Among authors: de la fuente revenga m. Schizophr Res. 2017 Nov;189:217-218. doi: 10.1016/j.schres.2017.02.005. Epub 2017 Feb 12. Schizophr Res. 2017. PMID: 28202291 Free PMC article. No abstract available.

32

Conformationally restrained carbamoylcholine homologues. Synthesis, pharmacology at neuronal nicotinic acetylcholine receptors and biostructural considerations.

de la Fuente Revenga M, Balle T, Jensen AA, Frølund B. de la Fuente Revenga M, et al. Eur J Med Chem. 2015 Sep 18;102:352-62. doi: 10.1016/j.ejmech.2015.07.029. Epub 2015 Jul 17. Eur J Med Chem. 2015. PMID: 26298493

33

Temperature and pH dependence of enzyme-catalyzed hydrolysis of trans-methylstyrene oxide. A unifying kinetic model for observed hysteresis, cooperativity, and regioselectivity.

Lindberg D, de la Fuente Revenga M, Widersten M. Lindberg D, et al. Among authors: de la fuente revenga m. Biochemistry. 2010 Mar 16;49(10):2297-304. doi: 10.1021/bi902157b. Biochemistry. 2010. PMID: 20146441

34

Snapshot IP₁ Detection Following 5-HT₂A Receptor Stimulation in the Mouse Brain.

de la Fuente Revenga M, González-Maeso J. de la Fuente Revenga M, et al. ACS Chem Neurosci. 2026 Jan 21;17(2):440-449. doi: 10.1021/acschemneuro.5c00932. Epub 2026 Jan 2. ACS Chem Neurosci. 2026. PMID: 41481361

35

Stereoselective, sex-dependent 5-HT_2A receptor modulation of cortical plasticity by MDMA in mice.

Gaines-Smith MC, Silverman JM, Fiorillo M, Younkin J, Moore KN, Maltman JL, de la Fuente Revenga M, Wolstenholme JT, Glennon RA, Dukat M, González-Maeso J. Gaines-Smith MC, et al. Among authors: de la fuente revenga m. Neuropsychopharmacology. 2026 Feb 2. doi: 10.1038/s41386-025-02313-x. Online ahead of print. Neuropsychopharmacology. 2026. PMID: 41629633 Free article.

36

Synthesis, pharmacological assessment, and molecular modeling of 6-chloro-pyridonepezils: new dual AChE inhibitors as potential drugs for the treatment of Alzheimer's disease.

Samadi A, de la Fuente Revenga M, Pérez C, Iriepa I, Moraleda I, Rodríguez-Franco MI, Marco-Contelles J. Samadi A, et al. Among authors: de la fuente revenga m. Eur J Med Chem. 2013 Sep;67:64-74. doi: 10.1016/j.ejmech.2013.06.021. Epub 2013 Jun 25. Eur J Med Chem. 2013. PMID: 23838422

37

Deep eutectic solvents (DESs) are viable cosolvents for enzyme-catalyzed epoxide hydrolysis.

Lindberg D, de la Fuente Revenga M, Widersten M. Lindberg D, et al. Among authors: de la fuente revenga m. J Biotechnol. 2010 Jun;147(3-4):169-71. doi: 10.1016/j.jbiotec.2010.04.011. Epub 2010 May 7. J Biotechnol. 2010. PMID: 20438773

38

EGR1-mediated repression of HDAC2 regulates BDNF-dependent kindling development in a mouse model of pentylenetetrazol-induced epilepsy.

Ibi D, Ishida K, Kojima T, Yoshida S, Suzuki A, Suzuki S, Yasui M, Shibuya K, Nakanishi M, Yamagami T, Saunders JM, de la Fuente Revenga M, Gonzalez-Maeso J, Hiramatsu M. Ibi D, et al. Among authors: de la fuente revenga m. Pharmacol Biochem Behav. 2026 Jan;258:174131. doi: 10.1016/j.pbb.2025.174131. Epub 2025 Nov 17. Pharmacol Biochem Behav. 2026. PMID: 41260527

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Results by year